Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-Benzylanthranilic acid, a derivative of N-aralkylanthranilic acids, is an organic compound with potential applications in the pharmaceutical industry. It is characterized by its ability to act as a central nervous system (CNS) depressant, which can be beneficial in certain medical contexts.

6622-55-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 6622-55-5 Structure
  • Basic information

    1. Product Name: N-BENZYLANTHRANILIC ACID
    2. Synonyms: 2-(BENZYLAMINO)BENZOIC ACID;N-BENZYLANTHRANILIC ACID;Anthranilic acid, N-benzyl-;N-Benzyl-o-aminobenzoic acid;2-[(phenylmethyl)amino]benzoic acid;2-(BEZYLAMINO)BENZOIC ACID;2-(N-BenzylaMino)benzoic Acid;NSC 54454
    3. CAS NO:6622-55-5
    4. Molecular Formula: C14H13NO2
    5. Molecular Weight: 227.26
    6. EINECS: 229-572-1
    7. Product Categories: Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts
    8. Mol File: 6622-55-5.mol
  • Chemical Properties

    1. Melting Point: 177-179°C
    2. Boiling Point: 409.5 °C at 760 mmHg
    3. Flash Point: 201.4 °C
    4. Appearance: /
    5. Density: 1.247 g/cm3
    6. Vapor Pressure: 1.93E-07mmHg at 25°C
    7. Refractive Index: 1.66
    8. Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. PKA: 3.89±0.10(Predicted)
    11. CAS DataBase Reference: N-BENZYLANTHRANILIC ACID(CAS DataBase Reference)
    12. NIST Chemistry Reference: N-BENZYLANTHRANILIC ACID(6622-55-5)
    13. EPA Substance Registry System: N-BENZYLANTHRANILIC ACID(6622-55-5)
  • Safety Data

    1. Hazard Codes: Xi,Xn
    2. Statements: 22-36/37/38
    3. Safety Statements: 26
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 6622-55-5(Hazardous Substances Data)

6622-55-5 Usage

Uses

Used in Pharmaceutical Industry:
N-Benzylanthranilic acid is used as a CNS depressant for its ability to reduce the activity of the central nervous system. This property makes it a potential candidate for the development of medications aimed at treating conditions that involve overexcitement or hyperactivity in the CNS, such as anxiety, insomnia, or certain neurological disorders.
The specific application reason for N-Benzylanthranilic acid in the pharmaceutical industry is its potential to act as a CNS depressant, which can help in managing conditions related to overactivity or hyperexcitability in the central nervous system.

Check Digit Verification of cas no

The CAS Registry Mumber 6622-55-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,2 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6622-55:
(6*6)+(5*6)+(4*2)+(3*2)+(2*5)+(1*5)=95
95 % 10 = 5
So 6622-55-5 is a valid CAS Registry Number.
InChI:InChI=1/C14H13NO2/c16-14(17)12-8-4-5-9-13(12)15-10-11-6-2-1-3-7-11/h1-9,15H,10H2,(H,16,17)

6622-55-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Benzylanthranilic Acid

1.2 Other means of identification

Product number -
Other names Benzoic acid, 2-[(phenylmethyl)amino]-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6622-55-5 SDS

6622-55-5Relevant articles and documents

Melatonin derivatives combat with inflammation-related cancer by targeting the Main Culprit STAT3

Ma, Shumeng,Zhu, Longqing,Fan, Xiaohong,Luo, Tian,Liu, Dan,Liang, Ziyi,Hu, Xiaoling,Shi, Tao,Tan, Wen,Wang, Zhen

, (2020/12/02)

The combination between two well-studied bioactive compounds melatonin and salicylic acid with proper modifications unexpectedly creates a sharp pair of “scissors” cutting off the vicious connection between inflammation and cancer by targeting a key contributor Signal Transducers and Activators of Transcription 3 (STAT3) in the two pathological processes. A representative compound P-3 with IC50 values on each tested cell line ranging from 7.37 to 18.62 μM among the designed melatonin derivatives is equipped with the ability of curbing inflammation-promoting cancer by down-regulating the expression, activation and nuclear translocation of STAT3, breaking the feedforward loop of STAT3 activation by decreasing the expression of pro-tumorigenic cytokines, and inducing cell apoptosis through ROS triggered Cyto-c/Caspase-3 pathway. This study suggests that the melatonin derivative P-3 is likely to become a promising chemical structure for developing the novel anti-cancer agents taking effect through hindering the mutual-promoting processes between inflammation and cancer.

Aminobenzoic acid derivatives as antioxidants and cholinesterase inhibitors; synthesis, biological evaluation and molecular docking studies

Iftikhar, Kiran,Murtaza, Shahzad,Kousar, Naghmana,Abbas, Aadil,Tahir, Muhammad Nawaz

, p. 385 - 396 (2018/04/23)

Cholinesterase namely, acetyl- and butyrylcholinesterase (AChE and BChE, respectively), has been recognized as a primary class of enzyme that hydrolyzes the acetylcholine (ACh) neurotransmitter in synaptic junctions. Diminished levels of the neurotransmitter in synaptic junction lead to Alzheimerís disease (AD). Inhibition of cholinesterase is thus, an attractive strategy for AD treatment. The study includes the synthesis and characterization of a series of 2-, 3- and 4-aminobenzoic acid derivatives (1a?5c), their biological screening against cholinesterase enzyme and molecular docking study to demonstrate putative binding modes. Antioxidant potential of the synthesized series was also determined. The cholinesterase enzyme inhibition assay showed that compound 5b has the highest inhibition potential against acetylcholinesterase with an IC50 value of 1.66 ± 0.03 μM while in case of butyrylcholinesterase, compound 2c has the highest inhibitory potential with an IC50 value of 2.67 ± 0.05 μM. Molecular docking studies supports the results of enzyme inhibition potential with binding energy value ?G = -9.54 Kcal mol-1 for compound 5b in case for acetylcholinesterase while for butyrylcholinesterase, ?G = -5.53 Kcal mol-1 was obtained for compound 2c. The synthesized series of compounds also shows mild to moderate antioxidant potential. The benzoyl- containing compounds shows better antioxidant activity as compared to other derivatives of the synthesized series. Based on the molecular docking studies and enzyme inhibition potential, the synthesized series of compounds can be regarded as potent cholinesterase inhibitors and can be used for designing and synthesizing more potent drugs for Alzheimerís disease and neurodegenerative diseases.

Sulfate Radical Anion (SO4?-) Mediated C(sp3)-H Nitrogenation/Oxygenation in N-Aryl Benzylic Amines Expanded the Scope for the Synthesis of Benzamidine/Oxazine Heterocycles

Laha, Joydev K.,Tummalapalli, K. S. Satyanarayana,Nair, Akshay,Patel, Nidhi

, p. 11351 - 11359 (2015/12/01)

A transition-metal-free, K2S2O8-mediated intramolecular oxidative nitrogenation/oxygenation of C(sp3)-H in N-aryl benzylic amines followed by oxidation at the benzylic center has been developed for the synthesis of benzamidine/benzoxazine heterocycles, providing an expedient access to quinazolin-4(3H)-ones, N-aryl-2-arylbenzimidazoles, and 4H-3,1-benzoxazin-4-ones. A considerable amount of work dealing with the mechanistic study to understand the crucial intramolecular cyclization step largely favors an iminium ion as the key intermediate.

Copper catalyzed C-N bond formation/C-H activation: Synthesis of aryl 4H-3,1-benzoxazin-4-ones

Munusamy, Sathishkumar,Venkatesan, Sathesh,Sathiyanarayanan, Kulathu Iyer

, p. 203 - 205 (2015/02/02)

We have developed a practical and efficient synthesis of 2-phenyl-4H-benzo[d][1,3]oxazine-4-one derivatives through copper catalyzed tandem reaction of 2-iodobenzoic acid with arylmethanamines under aerobic conditions. Compared to the literature methods toward the synthesis of 2-phenyl-4H-benzo[d][1,3]oxazine-4-one, the synthetic method reported in this Letter has broad substrate scope, mild reaction condition, and uses an inexpensive catalyst.

Direct synthesis of 2-aryl-4-quinolones via transition-metal-free intramolecular oxidative C(sp3)-H/C(sp3)-H coupling

Hu, Wei,Lin, Jian-Ping,Song, Li-Rui,Long, Ya-Qiu

supporting information, p. 1268 - 1271 (2015/05/20)

A novel, metal-free oxidative intramolecular Mannich reaction was developed between secondary amines and unmodified ketones, affording a simple and direct access to a broad range of 2-arylquinolin-4(1H)-ones through C(sp3)-H activation/C(sp3)-C(sp3) bond formation from readily available N-arylmethyl-2-aminophenylketones, using TEMPO as the oxidant and KOtBu as the base.

Palladium-catalyzed benzylic C-H benzylation via bis-benzylpalladium(II) complexes in water: An effective pathway for the direct construction of N-(1,2-diphenylethyl)anilines

Hikawa, Hidemasa,Izumi, Kyoko,Ino, Yukari,Kikkawa, Shoko,Yokoyama, Yuusaku,Azumaya, Isao

, p. 1037 - 1048 (2015/03/30)

A strategy for the N-benzylation/benzylic C-H benzylation cascade of anilines by the π-benzylpalladium system using a water-soluble palladium(0)/sodium diphenylphosphinobenzene-3-sulfonate (TPPMS) catalyst and benzyl alcohol in water has been developed. This tandem process is devised as a novel and efficient synthetic route for N-(1,2-diphenylethyl)anilines. Benzylic C-H activation of a mono-N-benzylated intermediate with a π-benzylpalladium(II) complex affords a bis-π-benzylated palladium(II) intermediate. The nucleophilic η1-σ-benzyl anion ligand attacks the electrophilic η3-π-benzyl ligand to give a dibenzylated product. The intermolecular competition between mono-N-benzylaniline and its monodeuterated form (monodeuterated at the benzylic group) with benzyl alcohol gave a KIE=4.6, suggesting that C-H bond cleavage was involved in the rate-determining step. Hammett studies on the rate constants of benzylation by various substituted anthranilic acids and mono-N-benzylanilines show a good correlation between the log(kX/kH) and the σ values of the respective substituents. From the slope, negative ρ values are obtained, suggesting that there is a build-up of positive charge in the transition state. The reaction of anilines with electron-donating and electron-withdrawing groups affords the corresponding N-(1,2-diphenylethyl)anilines in moderate to good yields (54-86%). Interestingly, the reaction of anthranilic acids proceeded smoothly to give only the corresponding dibenzylated products in good to excellent yields (70-87%). The carboxyl group of the anthranilic acids acts as a directing group in the benzylic C-H activation process.

Synthesis of 1-substituted 4(1H)-quinazolinones under solvent-free conditions

Wang, Yao,Zhang, Mei,Cao, Shengli,Lin, Huihui,Gao, Man,Li, Zhongfeng

, p. 2715 - 2727 (2012/07/14)

(Chemical Equation Presented) Heating a mixture of 2-(N-alkylamino)benzoic acids, triethyl orthoformate, and ammonium acetate under solvent-free conditions generated 1-substituted 4(1H)- quinazolinones in 73-99% yields. Moreover, a possible reaction pathway was proposed. Copyright Taylor & Francis Group, LLC.

Palladium-catalyzed benzylation of unprotected anthranilic acids with benzyl alcohols in water

Hikawa, Hidemasa,Yokoyama, Yuusaku

supporting information; experimental part, p. 6512 - 6515 (2012/02/02)

Palladium-catalyzed benzylation of unprotected anthranilic acids with benzyl alcohols in the presence of Pd(OAc)2 (5 mol %) and sodium diphenylphosphinobenzene-3-sulfonate (TPPMS, 10 mol %) in water at 120-C for 16 h gave only dibenzylated anthranilic acids in good yields. Water may play important roles for the smooth generation of the (?3-benzyl)palladium species by activation of the hydroxyl group of the benzyl alcohol. 2011 American Chemical Society.

Benzhydrylquinazolinediones: Novel cytosolic phospholipase A2α inhibitors with improved physicochemical properties

Kirincich, Steven J.,Xiang, Jason,Green, Neal,Tam, Steve,Yang, Hui Y.,Shim, Jaechul,Shen, Marina W.H.,Clark, James D.,McKew, John C.

experimental part, p. 4383 - 4405 (2009/10/23)

The synthesis and optimization of a class of trisubstituted quinazoline-2,4(1H,3H)-dione cPLA2α inhibitors are described. Utilizing pharmacophores that were found to be important in our indole series, we discovered inhibitors with reduced lipophilicity and improved aqueous solubility. These compounds are active in whole blood assays, and cell-based assay results indicate that prevention of arachidonic acid release arises from selective cPLA2α inhibition.

Efficient copper-catalyzed synthesis of N-alkylanthranilic acids via an ortho-substituent effect of the carboxyl group of 2-halobenzoic acids at room temperature

Zeng, Liang,Fu, Hua,Qiao, Renzhong,Jiang, Yuyang,Zhao, Yufen

supporting information; experimental part, p. 1671 - 1676 (2011/02/25)

We have developed an efficient copper-catalyzed method for the synthesis of N-alkylanthranilic acids. The protocol uses inexpensive copper(I) iodide/racemic 1,1'-binaphthyl-2,2'-diol (rac-BINOL) as the catalyst/ligand system, readily available 2-halobenzoic acids and aliphatic amines as the starting materials, the coupling reactions were performed at room temperature, and various functionalities in the substrates were tolerated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6622-55-5